Growth Metrics

Rigel Pharmaceuticals (RIGL) Change in Cash (2010 - 2026)

Rigel Pharmaceuticals' quarterly Change in Cash came in at -$16.2 million in Q1 2026, down 47.51% year-on-year from -$30.8 million in Q1 2025, and down 103.28% quarter-over-quarter from -$8.0 million in Q4 2025.

Rigel Pharmaceuticals has reported Change in Cash for 17 years, with the latest figure at -$16.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Cash fell 47.51% year-over-year to -$16.2 million; the trailing twelve-month figure through Mar 2026 stood at -$21.3 million (down 205.47% YoY), and the FY2025 full-year result was -$16.1 million, down 167.23% from the prior year.
  • Change in Cash for Q1 2026 stood at -$16.2 million, down from -$8.0 million in the prior quarter.
  • The five-year high for Change in Cash was $15.8 million in Q1 2023, with the low at -$16.2 million in Q1 2026.
  • Average Change in Cash over 5 years is $328117.6, with a median of $2.5 million recorded in 2022.
  • Year-over-year, Change in Cash soared 560.24% in 2024 and plunged 257.38% in 2025.
  • Tracing RIGL's Change in Cash over 5 years: stood at -$5.4 million in 2022, then slumped by 133.55% to -$12.6 million in 2023, then soared by 140.02% to $5.1 million in 2024, then sank by 257.38% to -$8.0 million in 2025, then slumped by 103.28% to -$16.2 million in 2026.
  • The last three Change in Cash figures came in at -$16.2 million (Q1 2026), -$8.0 million (Q4 2025), and -$4.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.44 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 623.00 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -2.44 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 417.10 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -153.10 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 53.61 Mn
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn -16.17 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -16.17 Mn
Dec 31, 2025 -7.95 Mn
Sep 30, 2025 -4.87 Mn
Jun 30, 2025 7.68 Mn
Mar 31, 2025 -10.96 Mn
Dec 31, 2024 5.05 Mn
Sep 30, 2024 15.64 Mn
Jun 30, 2024 10.48 Mn
Mar 31, 2024 -7.21 Mn
Dec 31, 2023 -12.63 Mn
Sep 30, 2023 -3.40 Mn
Jun 30, 2023 8.53 Mn
Mar 31, 2023 15.83 Mn
Dec 31, 2022 -5.41 Mn
Sep 30, 2022 2.67 Mn
Jun 30, 2022 2.52 Mn
Mar 31, 2022 5.79 Mn
Dec 31, 2021 -11.51 Mn
Sep 30, 2021 -54.42 Mn
Jun 30, 2021 64.78 Mn
Mar 31, 2021 -10.33 Mn
Dec 31, 2020 -6.19 Mn
Sep 30, 2020 98,000.00
Jun 30, 2020 -8.76 Mn
Mar 31, 2020 22.70 Mn
Dec 31, 2019 -16.57 Mn
Sep 30, 2019 -5.14 Mn
Jun 30, 2019 -30.47 Mn
Mar 31, 2019 -1.63 Mn
Dec 31, 2018 14.84 Mn
Sep 30, 2018 -3.59 Mn
Jun 30, 2018 24.95 Mn
Mar 31, 2018 1.84 Mn
Dec 31, 2017 12.41 Mn
Sep 30, 2017 -6.71 Mn
Jun 30, 2017 -7.55 Mn
Mar 31, 2017 22.51 Mn
Dec 31, 2016 -8.32 Mn
Sep 30, 2016 1.00 Mn
Jun 30, 2016 10.68 Mn
Mar 31, 2016 -29.19 Mn
Dec 31, 2015 4.88 Mn
Sep 30, 2015 21.29 Mn
Jun 30, 2015 -25.43 Mn
Mar 31, 2015 27.52 Mn
Dec 31, 2014 2.39 Mn
Sep 30, 2014 -11.07 Mn
Jun 30, 2014 8.97 Mn
Mar 31, 2014 -5.94 Mn
Dec 31, 2013 4.82 Mn
Sep 30, 2013 -5.84 Mn
Jun 30, 2013 -12.29 Mn
Mar 31, 2013 675,000.00
Dec 31, 2012 6.68 Mn
Sep 30, 2012 650,000.00
Jun 30, 2012 4.12 Mn
Mar 31, 2012 3.40 Mn
Dec 31, 2011 -49,000.00
Sep 30, 2011 -24.27 Mn
Jun 30, 2011 17.25 Mn
Mar 31, 2011 16.83 Mn
Dec 31, 2010 -13.18 Mn
Sep 30, 2010 -10.17 Mn